Cannara Biotech Inc. (TSXV:LOVE)

Market Cap	121.61M
Revenue (ttm)	94.07M
Net Income (ttm)	13.40M
Shares Out	91.43M
EPS (ttm)	0.14
PE Ratio	9.58
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,860
Average Volume	57,058
Open	1.340
Previous Close	1.320
Day's Range	1.310 - 1.340
52-Week Range	0.520 - 1.460
Beta	0.26
RSI	49.06
Earnings Date	Apr 28, 2025

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: LOVE

Financial Performance

In 2024, Cannara Biotech's revenue was 81.75 million, an increase of 42.77% compared to the previous year's 57.26 million. Earnings were 6.44 million, a decrease of -7.30%.